AmbioPharm presents three innovative strategies for peptide manufacturing built on a fragmentbased hybrid approach that integrates solid phase and liquid phase peptide synthesis to improve yield, purity, and sustainability when compared to traditional Solid Phase Peptide Synthesis.
Andrew Kennedy, Sales Manager - Europe, AmbioPharm
